| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
|
Ann Neurol
|
2004
|
21.56
|
|
2
|
Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.
|
J Cereb Blood Flow Metab
|
2005
|
6.25
|
|
3
|
Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.
|
J Med Chem
|
2003
|
5.34
|
|
4
|
Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative.
|
J Neuropathol Exp Neurol
|
2002
|
3.12
|
|
5
|
Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.
|
J Neurosci
|
2005
|
2.17
|
|
6
|
The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component.
|
J Neurosci
|
2003
|
2.06
|
|
7
|
Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer.
|
J Nucl Med
|
2012
|
2.00
|
|
8
|
A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain.
|
Bioorg Med Chem Lett
|
2002
|
1.79
|
|
9
|
Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease.
|
Neuroimage
|
2007
|
1.67
|
|
10
|
11C-JHU75528: a radiotracer for PET imaging of CB1 cannabinoid receptors.
|
J Nucl Med
|
2006
|
1.32
|
|
11
|
18F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: a first-in-human study of radiochemical safety, biokinetics, and radiation dosimetry.
|
J Nucl Med
|
2013
|
1.15
|
|
12
|
Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease.
|
J Mol Neurosci
|
2004
|
1.08
|
|
13
|
Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction.
|
J Am Coll Cardiol
|
2008
|
1.04
|
|
14
|
Recent PET radioligands with optimal brain kinetics for imaging nicotinic acetylcholine receptors.
|
J Labelled Comp Radiopharm
|
2013
|
0.93
|
|
15
|
PET Imaging of nicotinic acetylcholine receptors in baboons with 18F-AZAN, a radioligand with improved brain kinetics.
|
J Nucl Med
|
2011
|
0.89
|
|
16
|
18F-ASEM, a radiolabeled antagonist for imaging the α7-nicotinic acetylcholine receptor with PET.
|
J Nucl Med
|
2014
|
0.88
|
|
17
|
Derivatives of (-)-7-methyl-2-(5-(pyridinyl)pyridin-3-yl)-7-azabicyclo[2.2.1]heptane are potential ligands for positron emission tomography imaging of extrathalamic nicotinic acetylcholine receptors.
|
J Med Chem
|
2007
|
0.86
|
|
18
|
Human brain imaging of α7 nAChR with [(18)F]ASEM: a new PET radiotracer for neuropsychiatry and determination of drug occupancy.
|
Mol Imaging Biol
|
2014
|
0.84
|
|
19
|
New synthesis and evaluation of enantiomers of 7-methyl-2-exo-(3'-iodo-5'-pyridinyl)-7-azabicyclo[2.2.1]heptane as stereoselective ligands for PET imaging of nicotinic acetylcholine receptors.
|
Bioorg Med Chem Lett
|
2008
|
0.83
|
|
20
|
Synthesis and evaluation of new radioligands [(11)C]A-833834 and [(11)C]A-752274 for positron-emission tomography of α7-nicotinic acetylcholine receptors.
|
Nucl Med Biol
|
2013
|
0.83
|
|
21
|
Stable delineation of the ischemic area by the PET perfusion tracer 18F-fluorobenzyl triphenyl phosphonium after transient coronary occlusion.
|
J Nucl Med
|
2011
|
0.82
|
|
22
|
Microwave-assisted radiosynthesis of [(18) F]ASEM, a radiolabeled α7-nicotinic acetylcholine receptor antagonist.
|
J Labelled Comp Radiopharm
|
2015
|
0.82
|
|
23
|
A microwave radiosynthesis of the 4-[18F]-fluorobenzyltriphenylphosphonium ion.
|
J Labelled Comp Radiopharm
|
2014
|
0.81
|
|
24
|
Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptor.
|
Nucl Med Biol
|
2013
|
0.79
|
|
25
|
Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives.
|
J Mol Neurosci
|
2003
|
0.79
|
|
26
|
Synthesis and biological evaluation of novel carbon-11 labeled pyridyl ethers: candidate ligands for in vivo imaging of alpha4beta2 nicotinic acetylcholine receptors (alpha4beta2-nAChRs) in the brain with positron emission tomography.
|
Bioorg Med Chem
|
2009
|
0.78
|
|
27
|
Synthesis and evaluation of 2-(3'-iodo-4'-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in Alzheimer's disease.
|
J Mol Neurosci
|
2002
|
0.78
|
|
28
|
In vivo PET imaging of cardiac presynaptic sympathoneuronal mechanisms in the rat.
|
J Nucl Med
|
2008
|
0.78
|
|
29
|
Synthesis and in vivo evaluation of (S)-6-(4-fluorophenoxy)-3-((1-[11C]methylpiperidin-3-yl)methyl)-2-o-tolylquinazolin-4(3H)-one, a potential PET tracer for growth hormone secretagogue receptor (GHSR).
|
Bioorg Med Chem
|
2011
|
0.76
|
|
30
|
Quantitative Multi-modal Brain Autoradiography of Glutamatergic, Dopaminergic, Cannabinoid, and Nicotinic Receptors in Mutant Disrupted-In-Schizophrenia-1 (DISC1) Mice.
|
Mol Imaging Biol
|
2015
|
0.75
|
|
31
|
Identification of Three Novel Radiotracers for Imaging Aggregated Tau in Alzheimer's Disease with Positron Emission Tomography.
|
J Med Chem
|
2017
|
0.75
|